Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_587b3e28596d2acf12d60693e67d6ee3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_059b821dba0b0215fa69b744ffe8e9bb http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_29c29391f737109f5aae674de299fb5c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3f0657331dbe8aa5411eb321ff70de2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66579c43ee5f8fe0b706bf4af0e636f5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f77bd672b9f4ac01a01988a89707708 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2010-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_185bb95a39ee75c612604518344542b1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_575a116038122cc0c4bcd001fe4f1003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd5f9723bae2ea642e7a24f0df93dd9f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92304e402c9671b774095741e4813595 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b4e77f7f7e488ce492ac29a513cde1d |
publicationDate |
2012-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2012251536-A1 |
titleOfInvention |
Biopolymer hybrid gel-depot delivery system |
abstract |
The invention relates to biopolymer-gel based depot systems for prolonged and/or controlled release delivery of biologically active agents, methods for the manufacture of the biopolymer based gel-depots which include a biologically active agent, and uses of such biopolymer gel-depots in therapy. The biopolymer-gel based depot systems comprise a biocompatible polyaminosaccharide and/or protein; a biocompatible phosphate and/or sulphonamide compound; a biologically active agent; an aqueous insoluble alkaline earth metal phosphate; and a biocompatible glycan and/or proteoglycan. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019307885-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11672864-B2 |
priorityDate |
2009-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |